Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$268.26 - $339.48 $5.56 Million - $7.03 Million
20,720 New
20,720 $5.66 Million
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $2.69 Million - $3.65 Million
10,000 Added 67.39%
24,840 $8.02 Million
Q3 2023

Nov 14, 2023

BUY
$350.25 - $422.63 $3.48 Million - $4.2 Million
9,940 Added 202.86%
14,840 $5.32 Million
Q2 2023

Aug 14, 2023

BUY
$359.49 - $486.4 $826,827 - $1.12 Million
2,300 Added 88.46%
4,900 $1.86 Million
Q1 2023

May 15, 2023

BUY
$418.69 - $503.0 $1.09 Million - $1.31 Million
2,600 New
2,600 $1.25 Million
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $1.11 Million - $1.52 Million
2,700 New
2,700 $1.13 Million
Q2 2022

Aug 15, 2022

SELL
$463.67 - $597.16 $46,367 - $59,716
-100 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$524.57 - $735.42 $52,457 - $73,542
100 New
100 $56,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.42B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.